Application of ssc-miR-92b-3p in promoting pig embryo implantation

Through exosomal miRNA, especially ssc-miR-92b-3p, it promotes the proliferation and migration of trophoblast cells in pig embryos, reduces the expression of PFKM genes, solves the problem of spontaneous fetal loss in pig embryos, and improves the success rate of embryo engraftment. It has important application value in the pig farming industry.

CN115725494BActive Publication Date: 2024-11-15SOUTH CHINA AGRICULTURAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202211400260.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-09
Publication Date
2024-11-15
Estimated Expiration
2042-11-09

AI Technical Summary

Technical Problem

The spontaneous fetal loss rate of pig embryos in the early stage of pregnancy is high, and the existing technology is difficult to effectively solve, which affects the efficiency and economics of the pig farming industry.

Method used

Through exosomal miRNA, especially ssc-miR-92b-3p, the proliferation and migration of pig embryo trophoblast cells are promoted, and the PFKM gene expression is reduced, so as to improve the success rate of embryo engraftment.

Benefits of technology

It significantly improves the success rate of pig embryo engraftment, reduces the probability of spontaneous fetal loss, and provides new biotechnical means to promote embryo engraftment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115725494B_ABST
    Figure CN115725494B_ABST
Patent Text Reader

Abstract

The present invention provides the application of ssc-miR-92b-3p in promoting pig embryo implantation. The present invention has obtained the promoting effect of ssc-miR-92b-3p on pig embryo implantation and the inhibitory effect of ssc-miR-92b-3p on pig PFKM gene expression through a large number of studies; in addition, the present invention has also studied and obtained that inhibiting pig PFKM gene expression can promote pig embryo implantation, inhibiting the expression of pig PFKM gene by ssc-miR-92b-3p, promoting the proliferation and migration of pTr2 cells, and then promoting pig embryo implantation, reducing the probability of spontaneous fetal loss in pigs. The present invention can solve the problem of spontaneous fetal loss in the pig farming industry and has important value for the pig farming industry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and particularly relates to application of ssc-miR-92b-3p in promoting pig embryo implantation. Background Art

[0002] The most critical stage of pregnancy is the embryo implantation stage. Around the 12th day of pig pregnancy, pig embryos migrate between the uterine horns and make room for a suitable location to attach. The synchronous development ability of the embryos and the uterus's receptivity to embryo implantation are crucial for successful embryo implantation (embryo implantation). However, spontaneous fetal loss of pig embryos often occurs. According to statistics, about 20% to 45% of embryos are lost during pig pregnancy, and about 20% to 30% of embryos are lost in the pre-implantation period (12-30 days of pregnancy), which has become a major problem in the global commercial pig farming industry.

[0003] Early embryonic development occurs in a hypoxic environment of anaerobic glycolysis. In a hypoxic environment, placental cells are believed to promote glycolysis and inhibit mitochondrial metabolism. Phosphofructokinase-M (PFKM) is a key rate-limiting enzyme involved in the glycolysis energy metabolism pathway. The expression level of PFKM has a significant regulatory effect on the anaerobic glycolysis pathway of early embryos. However, the prior art only shows that changes in the expression level of PFKM can regulate the flux of embryonic anaerobic glycolysis, and does not explain whether changes in the expression level of PFKM are related to embryo implantation.

[0004] In the prior art, most of the research on the molecular level of pig pregnancy stages focuses on the changes in molecular expression levels, that is, the research on pregnancy detection diagnostic molecules. For example, the inventor's previous research showed that the expression level of ssc-miR-92b-3p in exosomes isolated from maternal serum in early pig pregnancy increased, which can be used as a diagnostic marker for early pregnancy in sows; Stacy MYadava et al. found that exosomes from the umbilical artery can be taken up by the placenta, and compared with pregnant women who delivered by early cesarean section, the expression level of ssc-miR-92b-3p in the placenta of pregnant women who delivered at full term was significantly increased; therefore, ssc-miR-92b-3p can be used as a molecular marker for pig pregnancy detection and diagnosis. For example, Huang Tao et al. found that ssc-miR-192, ssc-miR-146a-5p and ssc-miR-149 in early serum exosomes of sows can be jointly analyzed for the early pregnancy status of sows. However, the molecules whose expression levels change after pregnancy are physiological changes produced by the body after pregnancy occurs, and such research cannot be used to solve the problem of spontaneous fetal loss in pig embryos. It is of great significance to study the molecules that have a direct impact on the embryo implantation stage.

[0005] Finding methods to promote embryo implantation is of great necessity to the global pig industry. Summary of the invention

[0006] The present invention aims to solve the problem of high spontaneous fetal loss rate in pigs in the prior art and to provide a technology that can promote pig embryo implantation. According to the present invention, the proliferation and migration of pig embryo trophoblast cells are promoted by exosomal miRNA to achieve the purpose of promoting pig embryo implantation and reduce the probability of spontaneous fetal loss in pigs.

[0007] The primary purpose of the present invention is to provide an application of ssc-miR-92b-3p in promoting pig embryo implantation, or an application of ssc-miR-92b-3p in preparing a drug for promoting pig embryo implantation.

[0008] Another object of the present invention is to provide an application of a reagent for promoting the expression of ssc-miR-92b-3p in promoting pig embryo implantation, or in the preparation of a drug for promoting pig embryo implantation.

[0009] Another object of the present invention is to provide an application of ssc-miR-92b-3p in promoting the proliferation / migration of porcine embryonic trophoblast cells, or an application of ssc-miR-92b-3p in preparing a drug for promoting the proliferation / migration of porcine embryonic trophoblast cells.

[0010] Another object of the present invention is to provide an application of an agent for promoting the expression of ssc-miR-92b-3p in promoting the proliferation / migration of porcine embryonic trophoblast cells, or in the preparation of a drug for promoting the proliferation / migration of porcine embryonic trophoblast cells.

[0011] Another object of the present invention is to provide an application of an agent for inhibiting PFKM gene expression in promoting pig embryo implantation, or in the preparation of a drug for promoting pig embryo implantation.

[0012] Another object of the present invention is to provide an application of an agent for inhibiting PFKM gene expression in promoting the proliferation / migration of porcine embryonic trophoblastic cells, or in the preparation of a drug for promoting the proliferation / migration of porcine embryonic trophoblastic cells.

[0013] Another object of the present invention is to provide the use of ssc-miR-92b-3p in inhibiting the expression of porcine PFKM gene, or in preparing a drug for inhibiting the expression of porcine PFKM gene.

[0014] Another object of the present invention is to provide an application of an agent for promoting the expression of ssc-miR-92b-3p in inhibiting the expression of porcine PFKM gene, or in preparing a drug for inhibiting the expression of porcine PFKM gene.

[0015] Another object of the present invention is to provide a method for promoting pig embryo implantation.

[0016] The present invention achieves the above-mentioned invention object through the following technical solutions:

[0017] Our study found that ssc-miR-92b-3p was significantly expressed in the endometrium and embryonic tissues of pigs, and its expression level in the endometrial tissue of pregnant sows was significantly increased compared with that of empty sows.

[0018] pTr2 cells are an important cell type in embryonic development and play an important role in the growth and development of the fetus throughout pregnancy. On the 12th day of pregnancy, pig embryos rapidly transform from spherical to filamentous and determine their implantation positions. During this period of embryonic morphology and functional transformation, 30%-40% of embryos die due to failure to extend and make extensive contact between the trophectoderm and maternal endometrial epithelial cells. Our results found that ssc-miR-92b-3p can promote the proliferation and migration of pTr2 cells to promote embryo implantation. Therefore, by increasing the expression level of ssc-miR-92b-3p, the proliferation and migration of pTr2 cells are promoted to promote embryo implantation. We injected the inhibitor of ssc-miR-92b-3p into the uterine horns of mice and found that the number of embryo implantations in the uterine horns of mice injected with antago-miR-92b-3p was significantly reduced compared with the control group injected with DEPC water on the other side.

[0019] This study predicted PFKM as a target gene of ssc-miR-92b-3p through bioinformatics, and ssc-miR-92b-3p affects embryo implantation and growth through PFKM. Then, dual luciferase reporter experiments, RT-qPCR, and protein blot analysis proved that ssc-miR-92b-3p can inhibit the expression of PFKM gene at the mRNA and protein levels. The decrease in the expression level of PFKM gene will promote the proliferation and migration of pTr2 cells to promote embryo implantation. Interfering with the expression of PFKM gene can promote the proliferation and migration of pTr2 cells. Based on this, we infer that during the process of embryo implantation, the expression of PFKM gene in embryonic trophoblast cells decreases, preventing glycolysis from producing excessive ROS, thereby promoting embryo implantation.

[0020] Our results showed that the expression level of ssc-miR-92b-3p in the endometrium and embryos of pregnant sows during embryo implantation (P9, 12, 15) increased continuously and was significantly higher than that of empty sows (C9). In addition, ssc-miR-92b-3p can promote the proliferation and migration of porcine embryonic trophoblast (pTr2) cells. The target gene PFKM of ssc-miR-92b-3p was predicted by bioinformatics, and its targeting relationship was verified by dual luciferase reporter experiments, qPCR, WB and other experiments. It was found that interfering with the expression of the PFKM gene can significantly promote the proliferation and migration of pTr2 cells. We also found that reducing the expression of ssc-miR-92b-3p in the mouse uterus will lead to a decrease in the number of mouse embryo implantations.

[0021] Therefore, ssc-miR-92b-3p plays an important role during the embryo implantation process.

[0022] Based on the above research, the present invention provides the following applications and solutions:

[0023] The present invention provides application of ssc-miR-92b-3p in promoting pig embryo implantation, or application of ssc-miR-92b-3p in preparing a product for promoting pig embryo implantation; wherein the sequence of ssc-miR-92b-3p is UAUUGCACUCGUCCCGGCCUCC.

[0024] The present invention also provides the use of a reagent for promoting the expression of ssc-miR-92b-3p in promoting pig embryo implantation, or in preparing a product for promoting pig embryo implantation.

[0025] Preferably, the agent that promotes the expression of ssc-miR-92b-3p includes but is not limited to ssc-miR-92b-3pmimics.

[0026] The present invention also provides the use of ssc-miR-92b-3p in promoting the proliferation / migration of porcine embryonic trophoblast cells, or in preparing a product for promoting the proliferation / migration of porcine embryonic trophoblast cells.

[0027] The present invention also provides the use of a reagent for promoting the expression of ssc-miR-92b-3p in promoting the proliferation / migration of porcine embryonic trophoblastic cells, or in preparing a product for promoting the proliferation / migration of porcine embryonic trophoblastic cells.

[0028] Preferably, the agent that promotes the expression of ssc-miR-92b-3p includes but is not limited to ssc-miR-92b-3pmimics.

[0029] The invention also provides the use of the reagent for inhibiting the expression of PFKM gene in promoting pig embryo implantation, or in preparing the product for promoting pig embryo implantation.

[0030] The present invention also provides the use of an agent for inhibiting PFKM gene expression in promoting the proliferation / migration of pig embryo trophoblast cells, or in preparing a product for promoting the proliferation / migration of pig embryo trophoblast cells.

[0031] Preferably, the agent for inhibiting PFKM gene expression includes but is not limited to ssc-miR-92b-3p, si-PFKM-141, si-PFKM-879, si-PFKM-1586;

[0032] in,

[0033] The sequence of si-PFKM-141 is S:GGUUCGAGUUGGCAUCUAUTT;

[0034] AS:AUAGAUGCCAACUCGAACCTT;

[0035] The sequence of si-PFKM-879 is S:GGUAAAGCGUCUGGGAUAUTT;

[0036] AS:AUAUCCCAGACGCUUUACCTT

[0037] The sequence of si-PFKM-1586 is S:GCAUCCCGUUUGUGGUCAUTT;

[0038] AS:AUGACCACAAACGGGAUGCTT.

[0039] The present invention also provides the use of ssc-miR-92b-3p in inhibiting the expression of PFKM, or in preparing a product for inhibiting the expression of PFKM.

[0040] The present invention also provides the use of a reagent for promoting the expression of ssc-miR-92b-3p in inhibiting the expression of PFKM, or in preparing a product for inhibiting the expression of PFKM.

[0041] Preferably, the agent that promotes the expression of ssc-miR-92b-3p includes but is not limited to ssc-miR-92b-3pmimics.

[0042] The invention also provides a method for promoting pig embryo implantation and inhibiting pig PFKM gene expression.

[0043] Preferably, the expression of porcine PFKM gene is inhibited by ssc-miR-92b-3p or si-PFKM-141 or si-PFKM-879 or si-PFKM-1586;

[0044] in,

[0045] The sequence of si-PFKM-141 is S:GGUUCGAGUUGGCAUCUAUTT;

[0046] AS:AUAGAUGCCAACUCGAACCTT;

[0047] The sequence of si-PFKM-879 is S:GGUAAAGCGUCUGGGAUAUTT;

[0048] AS:AUAUCCCAGACGCUUUACCTT

[0049] The sequence of si-PFKM-1586 is S:GCAUCCCGUUUGUGGUCAUTT;

[0050] AS:AUGACCACAAACGGGAUGCTT.

[0051] As a preferred optional implementation,

[0052] The above-mentioned ssc-miR-92b-3p or si-PFKM-141 or si-PFKM-879 or si-PFKM-1586 is injected into the pig uterus to inhibit the expression of pig PFKM gene. The injection dose can be routinely adjusted according to the actual production situation.

[0053] The present invention also provides a method for promoting pig embryo implantation, and promoting the expression of pig ssc-miR-92b-3p.

[0054] Preferably, the expression of porcine ssc-miR-92b-3p is promoted by ssc-miR-92b-3p mimics.

[0055] As a preferred optional implementation,

[0056] The above-mentioned ssc-miR-92b-3p mimics are injected into the pig uterus to promote the expression of pig ssc-miR-92b-3p, and the injection dose can be routinely adjusted according to actual production conditions.

[0057] The present invention has the following beneficial effects:

[0058] The present invention provides a new application of ssc-miR-92b-3p in promoting pig embryo implantation, and studies show that ssc-miR-92b-3p promotes embryo implantation and that ssc-miR-92b-3p inhibits PFKM expression; in addition, the present invention also studies that inhibiting PFKM expression can promote embryo implantation, and inhibiting PFKM expression by ssc-miR-92b-3p promotes the proliferation and migration of pTr2 cells, thereby promoting pig embryo implantation and reducing the probability of spontaneous fetal loss in pigs. The present invention can solve the problem of spontaneous fetal loss in the pig farming industry, and has important value and significance for the pig farming industry. BRIEF DESCRIPTION OF THE DRAWINGS

[0059] Figure 1 is the expression of miR-93b-3p in endometrial tissue and embryo; Figure 1 A is the expression of ssc-miR-92b-3p in different tissues of pigs detected by real-time fluorescence quantitative PCR; Figure 1 B is the expression of ssc-miR-92b-3p in endometrial tissue and embryonic tissue detected by real-time fluorescence quantitative PCR on the 9th day of pseudofertilization (C9) and the 9th, 12th, and 15th days of pregnancy (P9, P12, and P15); Figure 1 C is the localization and expression of ssc-miR-92b-3p in endometrial tissue and embryonic tissue detected by fluorescence in situ hybridization at day 9 of pseudofertilization (C9) and days 9, 12, and 15 of pregnancy (P9, P12, and P15). In the figure, GE is glandular epithelial tissue, LE is luminal epithelial tissue, and Tr is embryonic tissue. The scale bar is 100 μm.

[0060] Figure 2 is the effect of ssc-miR-92b-3p on the proliferation ability of pTr2 cells; Figure 2 A is Example 2, in which the mimics and inhibitors of ssc-miR-92b-3p were transfected into pTr2 cells and the expression of ssc-miR-92b-3p was detected by RT-qPCR; Figure 2 B is the cell proliferation ability detected by CCk8 experiment in Example 2 after transfection with ssc-miR-92b-3pmimics / antagaomir; Figure 2 C and 2D are the Edu experiments in Example 2 to detect the cell proliferation ability after transfection with ssc-miR-92b-3p mimics / antagaomir; Figure 2 E and 2F are scratch experiments in Example 2 to detect the migration ability of cells after transfection with ssc-miR-92b-3p mimics / antagaomir.

[0061] Figure 3This is the verification experiment result of Example 3 ssc-miR-92b-3p targeted regulation of PFKM gene in pTr2 cells; wherein, Figure 3 A is the result of predicting ssc-miR-92b-3p target genes by PITA, miRanda and RNAhybrid analysis; Figure 3 B is the predicted binding site and mutation site of ssc-miR-92b-3p and 3'UTR of porcine PFKM gene; Figure 3 C shows the results of dual luciferase reporter gene assay after co-transfection of wild-type (WT) PFKM 3'UTR and ssc-miR-92b-3p mimics (ssc-miR-92b-3pmimics) and co-transfection of mutant (MUT) PFKM 3'UTR and ssc-miR-92b-3p mimics; Figure 3 D is the result of RT-qPCR analysis of the mRNA expression level of PFKM gene after transfection of ssc-miR-92b-3p mimics into pTr2 cells; Figure 3 E is the result of Western blot analysis of the protein expression level of PFKM gene after transfection of ssc-miR-92b-3p mimics; Figure 3 F is the result of Western blot analysis of the protein expression level of PFKM gene after transfection of ssc-miR-92b-3p inhibitor (ssc-miR-92b-3pantagaomir).

[0062] Figure 4 The experimental results of Example 4 on the effect of interfering with the expression of PFKM gene on the function of pTr2 cells; wherein, Figure 4 A is the interference effect of si-PFKM-141, si-PFKM-879, and si-PFKM-1586 on PFKM gene expression; Figure 4 B is Western blot analysis of the effect of si-PFKM-1586 on the protein expression level of PFKM gene; Figure 4 C is the experimental result of CCk8 experiment; Figure 4 D is the staining result of Edu experiment; Figure 4 E is the statistical result of the Edu experiment; Figure 4 F shows the effect of interfering with PFKM gene expression on the migration of pTr2 cells.

[0063] Figure 5 The experimental results of Example 5 verifying the effect of ssc-miR-92b-3p in the process of mouse embryo implantation; Figure 5 A shows the effects of injecting antago-miR-92b-3p (left) and DEPC water (right) into the uterine horns of mice on mouse embryo implantation; Figure 5B is a comparison of the number of embryo implantation sites in the uterine horns of mice injected with antago-miR-92b-3p (left) and DEPC water (right). DETAILED DESCRIPTION

[0064] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0065] Unless otherwise specified, the reagents used in the examples are conventional reagents in the art and can be purchased through commercial channels. The experimental operations not specifically described in the examples are conventional operations in the art or can be understood or known by those skilled in the art based on the existing technology or common knowledge they master.

[0066] The following are some of the materials and reagents used in the present invention:

[0067] Porcine trophoblast cell line (porcine trophoblast PTr2).

[0068] Fetal bovine serum, DMEM / F12 medium, trypsin (Gibco, USA);

[0069] Lipofectamine 3000Transfection Reagent, PowerUP SYBR Green Master Mix (USA, Thermo Fisher);

[0070] TRIzol, BCA protein quantification kit (Invitrogen, USA);

[0071] Insulin human recombinant, Cell Counting Kit (CCK-8) (Yishen, China);

[0072] BeyoClick EdU-555 cell proliferation detection kit (Beyotime, China);

[0073] PrimeScriptTM RT reagent Kit with gDNAEraser (Perfect Real Time) (Japan, TaKaRa);

[0074] PVDF membrane (Millipore, USA);

[0075] Tubulin antibody (Sevier, China), PFKM antibody (Abcam, UK);

[0076] ssc-miR-92b-3p antagomir / mimics and PFKM small interfering protein (si-PFKM) and control (China, Jimma).

[0077] In the experimental process of the present invention, the data results of RT-qPCR, WB, etc. are from the mean ± standard deviation of at least three independent experiments. GraphPad Prism8.0 software is used to analyze the data and draw graphs. The independent sample t-test is used for comparison between the two groups. P < 0.05 indicates a significant difference, which is indicated by * in the figure, and P < 0.01 indicates an extremely significant difference, which is indicated by ** or **** in the figure.

[0078] Example 1 Expression of ssc-miR-92b-3p in endometrium and embryonic tissues increases in early pregnancy of sows

[0079] 1. Tissue sample collection

[0080] In this example, healthy large white pigs of similar age and genetic background were selected, and estrus synchronization treatment was performed on them. After estrus was observed, they were artificially inseminated (recorded as day 0). One group (8 pigs) was sham insemination (non-pregnant group), and the other group (8 pigs) was inseminated with frozen fresh semen (artificial insemination). After the completion of artificial insemination, the sows were considered to be in a pregnant state.

[0081] Among them, the treatment methods for synchronous estrus are as follows:

[0082] On days 14-18 of the estrus cycle, 20 mg of progesterone is fed to each sow daily, and sows will go into estrus within 4-8 days after feeding is stopped.

[0083] (1) Endometrial tissue

[0084] The uteri of sows on the 9th day of pseudo-fertilization and the 9th, 12th, and 15th days of pregnancy were respectively obtained, the inner side of the uterus was opened longitudinally and the endometrial tissue was collected, immediately frozen in liquid nitrogen and transferred to a -80°C refrigerator for storage.

[0085] (2) Embryonic tissue

[0086] On the 9th day of pseudofertilization and the 9th, 12th, and 15th days of pregnancy, the sows were dissected, the uterus of the pigs was taken out, and the embryos were flushed out of the uterus from one side of the uterus with DPBS, immediately frozen in liquid nitrogen, and transferred to a -80°C refrigerator for storage.

[0087] (3) Sampling of pig tissues

[0088] After the sows were slaughtered, the various tissues of the pig (heart, liver, spleen, lungs, kidneys, brain, ovaries, and fallopian tubes) were taken out and cleaned with DPBS. A small piece of each tissue was placed in a cryopreservation tube, immediately placed in liquid nitrogen, and then transferred to a -80°C refrigerator for storage.

[0089] 2. Real-time quantitative PCR (RT-qPCR)

[0090] Real-time fluorescence quantitative PCR (RT-qPCR) was used to detect the expression level of ssc-miR-92b-3p in various tissues of pigs. In order to determine whether ssc-miR-92b-3p was related to embryo implantation, the expression level of ssc-miR-92b-3p in the endometrium and embryonic tissues of empty sows and early pregnant pigs was detected by RT-qPCR.

[0091] (1) Experimental methods

[0092] RNA was extracted from embryonic trophoblast cells, endometrium, and pig tissues (heart, liver, spleen, lung, kidney, brain, ovary, and fallopian tube) using TRIzol, and the RNA concentration was determined using a spectrophotometer. The RNA was reverse transcribed into cDNA using a reverse transcription kit (TaKaRa), and then the qPCR reaction system was prepared (as shown in Table 1). The relative expression level of the gene was determined using a fluorescence quantitative PCR instrument. The fluorescence quantitative PCR program is shown in Table 2. The expression levels of ssc-miR-92b-3p and genes were measured using U6 and β-actin as internal references according to 2 -ΔΔCt Formula calculation.

[0093] The primer sequences used for reverse transcription to generate cDNA are:

[0094] 5'-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGGAGGCCG-3'

[0095] The primer sequences used for RT-qPCR are:

[0096] Ssc-miR-92b-3p-Fq: CTGGTAGGTATTGCACTCGTCCCG

[0097] Ssc-miR-92b-3p-Rq: CTCAACTGGTGTCGTGGA

[0098] Table 1 Realtime PCR system

[0099]

[0100]

[0101] Table 2 qPCR procedure (two-step method):

[0102]

[0103] (2) Experimental results

[0104] RT-qPCR experimental results are as follows Figure 1 A and Figure 1 As shown in B, the results showed that ssc-miR-92b-3p was widely expressed in a series of pig tissues ( Figure 1 A). The expression of ssc-miR-92b-3p in endometrial and embryonic tissues gradually increased on pseudofertilization day 9 (C9) and pregnancy days 9, 12, and 15 (P9, 12, and 15).

[0105] 3. Fluorescence in situ hybridization (FISH)

[0106] FISH was used to detect the localization and relative quantification of ssc-miR-92b-3p in endometrial tissue and embryonic tissue. The probe sequence of ssc-miR-92b-3p was 5'-UAUUGCACUCGUCCCGGCCUCC-3'Cy3 red labeling. Fluorescence in situ hybridization was performed by Wuhan Saiweier Biotechnology Co., Ltd.

[0107] (1) The basic operation process is as follows:

[0108] After washing, the endometrial tissue (with embryonic tissue in the endometrial tissue) was immediately fixed in 4% paraformaldehyde for more than 12 hours. After fixation, it was dehydrated with gradient alcohol and then immersed in wax for embedding. After slicing, it was placed in a 62℃ oven for 2 hours, and the slices were dewaxed and dehydrated in turn. After natural drying, the slices were boiled in the repair solution for 10-15 minutes, cooled naturally, and proteinase K (20μg / mL) was added to digest at 37℃. After rinsing with pure water, PBS was washed 3 times, each time for 5 minutes. Prehybridization solution was added to the slices, incubated at 37℃ for 1 hour, the prehybridization solution was removed, and the hybridization solution containing the probe was added to hybridize overnight in a 37℃ incubator. After incubation, the hybridization solution was washed away, and 2xSSC was used to wash at 37℃ for 10 minutes, 1xSSC was used to wash at 37℃ for 2x5 minutes, and 0.5xSSC was used to wash at room temperature for 10 minutes. DAPI staining solution was added to incubate for 8 minutes in a light-proof environment, and anti-fluorescence quenching sealing agent was added to seal the slices after rinsing. The sections were observed under a fluorescence microscope and images were collected.

[0109] (2) Experimental results

[0110] The results of fluorescence in situ hybridization were Figure 1C. The results showed that the expression level of ssc-miR-92b-3p in endometrial tissues at P9, P12, and P15 gradually increased, and the expression level of ssc-miR-92b-3p in embryonic tissues also gradually increased in these three periods.

[0111] The above experimental results indicate that miR-92b-3p increases in both the endometrium and embryonic tissue during the embryo implantation stage, and may play an important role in embryo implantation.

[0112] Example 2 Effect of ssc-miR-92b-3p on the function of embryonic trophoblast cells (pTr2)

[0113] In order to explore the role of ssc-miR-92b-3p in embryonic trophoblast cells (pTr2), ssc-miR-92b-3pmimics / antagaomir (ssc-miR-92b-3p mimics / inhibitors) were transfected into embryonic trophoblast cells (pTr2), and pTr2 cells transfected with ssc-miR-92b-3p Inhibitor NC / mimics NC were used as control. RT-qPCR was used to detect the expression level of ssc-miR-92b-3p, CCK-8 experiment and Edu experiment were used to detect the proliferation of pTr2, and the scratch experiment was used to detect the migration of pTr2.

[0114] 1. Culture of embryonic trophoblast cells (pTr2)

[0115] pTr2 was cultured in 10 cm plates in DMEM / F12 basal medium supplemented with 1% bispecific antibody (Gibco), 0.5% insulin (Yisheng) and 10% fetal bovine serum (Gibco), and cultured in a constant temperature cell culture incubator at 5% CO2 and 37°C. When the cell density reached 80%, it was digested with 0.25% trypsin, plated and subjected to subsequent experiments.

[0116] 2. Cell Transfection

[0117] pTr2 cells in the logarithmic growth phase were seeded in 6-well plates and cultured overnight until the cell density reached 50% to 70%. Then, ssc-miR-92b-3pmimics / antagomir / mimics NC / inhibitor NC were transfected with Lipofectamine 3000 Transfection Reagent. After transfection, the cells were placed in a cell culture incubator for continued culture. The medium was changed after 8 hours for subsequent experiments.

[0118] The sequence of ssc-miR-92b-3p mimics is: S:UAUUGCACUCGUCCCGGCCUCC

[0119] AS:AGGCCGGGACGAGUGCAAUAUU

[0120] The sequence of ssc-miR-92b-3p antagomir is: GGAGGCCGGGACGAGUGCAAUA

[0121] The sequence of ssc-miR-92b-3p mimicsNC is: S:UUCUCCGAACGUGUCACGUTT

[0122] AS:ACGUGACACGUUCGGAGAATT

[0123] The sequence of ssc-miR-92b-3p inhibitor NC is: CAGUACUUUUGUGUAGUACAA

[0124] 3. RT-qPCR Experiment

[0125] (1) Experimental methods

[0126] The pTr2 cells transfected with ssc-miR-92b-3p mimics / antagomir / mimics NC / inhibitor NC were subjected to RT-qPCR experiment to detect the expression of ssc-miR-92b-3p. The specific experimental process was the same as that in Example 1.

[0127] (2) Experimental results

[0128] RT-qPCR results showed that the expression level of ssc-miR-92b-3p was significantly increased after transfection with ssc-miR-92b-3p mimics, while the expression level of ssc-miR-92b-3p was significantly decreased after transfection with ssc-miR-92b-3pantagaomir ( Figure 2 A).

[0129] 4. Cell-Counting Kit-8 (CCK-8) Experiment

[0130] (1) Experimental methods

[0131] The CCK-8 kit (CCK-8, Shanghai Yisheng Biotechnology Co., Ltd.) was used to detect the cell proliferation activity 12h, 24h, 48h, and 72h after transfection with ssc-miR-92b-3pmimics / antagomir / mimics NC / inhibitor NC.

[0132] Take the pTr2 cells in a 10 cm plate with good growth status and a growth density of 90%, digest the cells from the cell culture plate with 0.25% trypsin, centrifuge to remove the supernatant, add 30 mL of DMEM / F12 medium containing 10% FBS, mix to obtain a cell suspension, and spread it in 4 96-well plates. Add 100 μL of cell suspension to each well of each 96-well plate. When the cell density reaches about 40%, transfect the cells with ssc-miR-92b-3p mimics / antagomir / mimics NC / inhibitorNC, add 10 μL of CCK8 solution to each well of the cells at 12 h, 24 h, 48 h, and 72 h, respectively, and place them in a 37°C cell culture incubator for 2 h. Then use a multifunctional microplate reader to measure the optical density (OD) of each well plate at 450 nm.

[0133] (2) Experimental results

[0134] Cell-Counting Kit-8 (CCK-8) results showed that the increase of ssc-miR-92b-3p significantly promoted the proliferation of pTr2, and the decrease of ssc-miR-92b-3p significantly inhibited the proliferation of pTr2 ( Figure 2 B).

[0135] 5. Edu Experiment

[0136] (1) Experimental methods

[0137] BeyoClickTMEdu-555 cell proliferation detection kit (Shanghai Beyotime Biotechnology Co., Ltd.) was used to detect cell proliferation 48 hours after transfection of ssc-miR-92b-3p mimics / antagomir / mimics NC / inhibitor NC.

[0138] Take pTr2 cells from a 10 cm plate with good growth and a growth density of 90%, transfer the cells to a 96-well plate (the plating process is the same as the CCK-8 experiment), and when the cell density reaches about 40%, transfect the cells with ssc-miR-92b-3pmimics / antagomir / mimics NC / inhibitor NC, 48h after transfection, add the prepared 2X Edu working solution to the 96-well plate, and culture in a cell culture incubator at 37℃, 5% CO2 for 2h to complete Edu labeling; after Edu labeling, remove the culture medium, wash twice with DPBS, 3min each time, fix with 4% paraformaldehyde at room temperature for 15min, wash twice with DPBS, permeabilize with cell permeabilization solution (Shanghai Biyuntian Biotechnology Co., Ltd.) for 10min, then wash twice with DPBS, add 70μL of the prepared Click reaction solution (prepared according to the instructions of the kit) to each well (96-well plate), incubate at room temperature in the dark for 30min, discard the Click reaction solution, wash twice with DPBS, finally add DAPI to incubate at room temperature for 8min to stain the cell nucleus, discard the DAPI solution, wash twice with DPBS, and then perform fluorescence detection. The specific process is to take pictures using a Nikon fluorescence inverted microscope. The red cells in the results are newly proliferated cells, and the number of cells is counted manually.

[0139] (2) Experimental results

[0140] The results of the Edu experiment showed that the increase of ssc-miR-92b-3p significantly promoted the proliferation of pTr2; the decrease of ssc-miR-92b-3p significantly inhibited the proliferation of pTr2 ( Figure 2 C. Figure 2 D).

[0141] 6. Scratch test

[0142] (1) Experimental methods

[0143] 48 hours after cells were transfected with ssc-miR-92b-3p mimics / antagomir / mimics NC / inhibitor NC, a large pipette tip was used to vertically scratch a linear wound on a 6-well plate, and the cell culture medium was replaced with serum-free medium. Cell migration and wound healing were observed and photographed at 0 and 12 hours. Three fields of view were randomly selected and the healing area was calculated using ImageJ software to obtain the cell migration rate.

[0144] (2) Experimental results

[0145] The results of the scratch assay showed that the increase of ssc-miR-92b-3p significantly promoted the migration of pTr2; the decrease of ssc-miR-92b-3p significantly inhibited the migration of pTr2 ( Figure 2E. Figure 2 F).

[0146] Figure 2 In the expression, miRNAmimicsNC means ssc-miR-92b-3p mimicsNC; miR-92b-3p mimics means ssc-miR-92b-3p mimics; miRNAinhibitor NC means ssc-miR-92b-3p inhibitor NC; miR-92b-3p antagomir means ssc-miR-92b-3p antagomir.

[0147] Based on the above experimental results, the increase of ssc-miR-92b-3p significantly promoted the proliferation and migration of pTr2; the decrease of ssc-miR-92b-3p significantly inhibited the proliferation and migration of pTr2.

[0148] Example 3 ssc-miR-92b-3p targeted regulation of PFKM gene in pTr2 cells

[0149] PFKM was predicted as a target of ssc-miR-92b-3p using PITA, miRanda, and RNAhybrid analysis ( Figure 3 A). Then, wild-type (WT) and mutant (MUT) luciferase reporter plasmids carrying PFKM 3'-UTR were constructed (PGLO-PFKM-WT and PGLO-PFKM-MUT), and the targeting relationship between the two was further verified by dual-luciferase reporter gene assay.

[0150] I. Plasmid construction and dual-luciferase reporter gene assay

[0151] (1) Plasmid construction

[0152] The 3'-UTR binding site of the porcine PFKM gene that binds to ssc-miR-92b-3p was cloned into the PGLO vector to construct a wild-type (WT) dual-luciferase reporter plasmid, and a mutant (MUT) luciferase reporter plasmid was constructed by site-directed mutagenesis ( Figure 3 B).

[0153] (2) Dual luciferase reporter gene assay

[0154] PK-15 cells (pig kidney cells) were cultured in DMEM basal medium supplemented with 1% double antibody (Gibco) and 5% fetal bovine serum in a constant temperature cell culture incubator at 5% CO2 and 37°C. 4Each well was inoculated into a cell culture plate. When the cell density reached 60%-80%, ssc-miR-92b-3p mimics and dual luciferase reporter plasmid (PGLO-PFKM-WT or PGLO-PFKM-MUT) were transfected into PK-15 cells using Lipofectamine 3000 transfection reagent. The medium was changed 6 hours after transfection. Cells were collected 24 hours after transfection, and the luciferase activity was detected using a dual luciferase detection kit (Yishen).

[0155] (3) Experimental results

[0156] The experimental results are as follows Figure 3 As shown in C, the results showed that when ssc-miR-92b-3p mimics were co-transfected with the wild-type luciferase reporter plasmid (PGLO-PFKM-WT), the luciferase activity was significantly reduced; however, when ssc-miR-92b-3p mimics were co-transfected with the mutant luciferase reporter plasmid (PGLO-PFKM-MUT), the luciferase activity did not change significantly ( Figure 3 C). The results showed that ssc-miR-92b-3p directly targeted the PFKM gene.

[0157] Real-time fluorescence quantitative (qPCR) experiments and western blot analysis (WB) were used to verify the targeting relationship between miR-92b-3p and the PFKM gene.

[0158] 2. Real-time fluorescence quantitative PCR (qPCR)

[0159] (1) Experimental methods

[0160] pTr2 cells were transfected with ssc-miR-92b-3p mimics, and pTr2 cells transfected with ssc-miR-92b-3p mimicsNC were used as controls. Cell RNA was extracted 48 h after transfection, and the RNA expression level of the PFKM gene was detected by real-time fluorescence quantitative PCR. The specific process was the same as in Example 1.

[0161] (2) Experimental results

[0162] The results of real-time fluorescence quantitative PCR are as follows Figure 3 As shown in D, the results showed that the RNA expression level of the PFKM gene was decreased after pTr2 cells were transfected with ssc-miR-92b-3pmimics.

[0163] 3. Western Blot Analysis (WB)

[0164] (1) Experimental methods

[0165] pTr2 cells were transfected with ssc-miR-92b-3p mimics and ssc-miR-92b-3p antagomir and cultured for 48 hours, and then cell proteins were extracted. pTr2 cells transfected with ssc-miR-92b-3p mimicsNC / inhibitor NC were used as controls. The transfected cells were lysed with RIPA lysis buffer containing protease inhibitors to extract proteins. The samples were denatured by heating, and the proteins were separated by SDS-PAGE electrophoresis and transferred to PVDF membranes. They were blocked with 5% skim milk for 2.5 hours at room temperature on a shaker, washed with TBST, and incubated overnight at 4°C with PFKM antibody (Abcam, 1:1000) and tubulin antibody. After washing with TBST three times, goat anti-rabbit IgG or anti-mouse IgG secondary antibody (1:2000) was added and incubated at 37°C for 1 hour. The target protein bands were developed using chemiluminescent solution, and the relative protein levels were quantified using Image J software.

[0166] (2) Experimental results

[0167] The results of Western blot analysis showed that after pTr2 cells were transfected with ssc-miR-92b-3p mimics, the protein expression level of PFKM gene decreased ( Figure 3 E); after transfection with ssc-miR-92b-3p antagomir, the protein level expression was significantly increased ( Figure 3 F).

[0168] The above results showed that PFKM gene was the target gene of ssc-miR-92b-3p.

[0169] Phosphofructokinase (PFKM) is an enzyme that catalyzes fructose-6-phosphate to fructose-1,6-bisphosphate, and is a key rate-limiting enzyme in the glycolysis process. The abundance of glucose and fructose in the pig uterine cavity increases during the embryo implantation period, and is used as the main energy substrate for fetal growth and development. Excessive glycolysis in mammals will cause a large amount of NADPH to be produced, and the electrons in NADPH will be transferred to oxygen through NOX (NADPH oxidase) expressed on the plasma membrane and endoplasmic reticulum, which will produce a large amount of ROS.

[0170] Example 4 Effect of PFKM gene in pTr2 cells

[0171] In order to explore the functional effect of PFKM on pTr2 cells, three interference fragments (si-PFKM-141, si-PFKM-879, si-PFKM-1586) at different positions were designed for the PFKM gene, and these three si-PFKMs were transfected into pTr2 cells respectively (transfection method was the same as in Example 2), and real-time fluorescence quantitative PCR (method was the same as in Example 1) and protein immunoblot analysis (method was the same as in Example 3) were used to detect the RNA and protein expression levels of the PFKM gene after transfection with si-PFKM.

[0172] The sequences of the above three interference fragments are as follows:

[0173] Sequence of si-PFKM-141: S:GGUUCGAGUUGGCAUCUAUTT

[0174] AS:AUAGAUGCCAACUCGAACCTT

[0175] Sequence of si-PFKM-879: S:GGUAAAGCGUCUGGGAUAUTT

[0176] AS:AUAUCCCAGACGCUUUACCTT

[0177] Sequence of si-PFKM-1586: S:GCAUCCCGUUUGUGGUCAUTT

[0178] AS:AUGACCACAAACGGGAUGCTT

[0179] The results of real-time fluorescence quantitative PCR showed that the three interference fragments, si-PFKM-141, si-PFKM-879, and si-PFKM-1586, could reduce the expression level of the PFKM gene, but the small interference fragment si-PFKM-1586 had the most significant effect in interfering with the expression of the PFKM gene and was the most effective in inhibiting the expression of the PFKM gene ( Figure 4 A), Western blot analysis results showed that si-PFKM-1586 could significantly interfere with the expression level of PFKM gene protein ( Figure 4 B).

[0180] Therefore, si-PFKM-1586 was selected for subsequent functional verification.

[0181] The pTr2 cells transfected with si-PFKM-1586 were further subjected to CCK-8 assay (the specific experimental process was the same as in Example 2), Edu assay (the specific experimental process was the same as in Example 2) and scratch assay (the specific experimental process was the same as in Example 2) to detect the effect of si-PFKM-1586 on the proliferation and migration of pTr2 cells.

[0182] CCK-8( Figure 4 C) and Edu( Figure 4 D. Figure 4 E) The experimental results showed that si-PFKM-1586 significantly promoted the proliferation of pTr2 cells, that is, interfering with the expression of PFKM can significantly promote the proliferation of pTr2 cells; the scratch experiment showed that interfering with the expression of PFKM can significantly promote the migration of pTr2 cells ( Figure 4 F).

[0183] Example 5 Inhibition of ssc-miR-92b-3p expression in a mouse model hinders implantation of mouse embryos

[0184] We further verified the role of ssc-miR-92b-3p in embryo implantation using an in vivo mouse model. On the third day of mouse pregnancy, ssc-miR-92b-3p antagomir was injected into one uterine horn of the mouse uterus, and DEPC water was injected into the other uterine horn as a control. The specific process was that on the third day of mouse pregnancy, the pregnant mice were anesthetized, and 10μL solution of 20μM ssc-miR-92b-3p antagomir or 10μL DEPC water was injected into the uterine horns on both sides, the wounds were sutured, and the mice were placed in a 37-degree environment to wake up. On the seventh day of pregnancy, the mice were dissected and the embryo implantation was observed, and the number of embryo implantations was counted.

[0185] The experimental results are as follows Figure 5 As shown in the results, the number of embryo implantation in the uterus injected with ssc-miR-92b-3p antagomir was significantly lower than that in the control group on the other side ( Figure 5 A. Figure 5 B).

[0186] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. Use of an agent for inhibiting PFKM gene expression in the preparation of a product for promoting pig embryo implantation, wherein the agent for inhibiting PFKM gene expression is selected from any one or more of the following: (1) si-PFKM-141, sequence: S:GGUUCGAGUUGGCAUCUAUTT; AS:AUAGAUGCCAACUCGAACCTT; (2) si-PFKM-879, sequence: S:GGUAAAGCGUCUGGGAUAUTT; AS:AUAUCCCAGACGCUUUACCTT (3) si-PFKM-1586, sequence: S:GCAUCCCGUUUGUGGUCAUTT; AS:AUGACCACAAACGGGAUGCTT.

2. Use of an agent for inhibiting PFKM gene expression in the preparation of a product for promoting the proliferation / migration of porcine embryonic trophoblast cells, wherein the agent for inhibiting PFKM gene expression is selected from any one or more of the following: (1) si-PFKM-141, sequence: S:GGUUCGAGUUGGCAUCUAUTT; AS:AUAGAUGCCAACUCGAACCTT; (2) si-PFKM-879, sequence: S:GGUAAAGCGUCUGGGAUAUTT; AS:AUAUCCCAGACGCUUUACCTT (3) si-PFKM-1586, sequence: S:GCAUCCCGUUUGUGGUCAUTT; AS:AUGACCACAAACGGGAUGCTT.

3. A product for promoting pig embryo implantation, It is characterized in that Contains an agent for inhibiting the expression of the porcine PFKM gene, wherein the agent for inhibiting the expression of the PFKM gene is selected from any one or more of the following: (1) si-PFKM-141, sequence: S:GGUUCGAGUUGGCAUCUAUTT; AS:AUAGAUGCCAACUCGAACCTT; (2) si-PFKM-879, sequence: S:GGUAAAGCGUCUGGGAUAUTT; AS:AUAUCCCAGACGCUUUACCTT (3) si-PFKM-1586, sequence: S:GCAUCCCGUUUGUGGUCAUTT; AS:AUGACCACAAACGGGAUGCTT.

Citation Information

Patent Citations

  • Application of serum exosome ssc-miR-92b-3p as molecular marker for early pregnancy diagnosis of sows

    CN110804659A

  • Biomarkers For Endometriosis

    US20170016067A1